{"id":34261,"date":"2020-03-25T19:07:16","date_gmt":"2020-03-25T19:07:16","guid":{"rendered":"https:\/\/beyondtype2.org\/?page_id=34261"},"modified":"2024-12-09T19:08:25","modified_gmt":"2024-12-09T19:08:25","slug":"inmunoterapias","status":"publish","type":"page","link":"https:\/\/beyondtype1.org\/es\/inmunoterapias\/","title":{"rendered":"Inmunoterapias"},"content":{"rendered":"<p><em>Este Recurso en&nbsp;<a href=\"https:\/\/beyondtype1.org\/es\/investigacion\/\" data-wpel-link=\"internal\">Investigaci&oacute;n sobre Diabetes Tipo 1&nbsp;<\/a>fue creado en colaboraci&oacute;n con JDRF como parte de la Alianza&nbsp;<a href=\"https:\/\/beyondtype1.org\/es\/jdrf-y-beyond-type-1-presentan-alianza-para-servir-a-la-comunidad-de-diabetes-tipo-1-dt1\/\" data-wpel-link=\"internal\">JDRF &ndash; Beyond Type 1&nbsp;<\/a><\/em><\/p>\n<hr>\n<p>&nbsp;<\/p>\n<div class=\"jhH5U\">\n<div id=\"tw-ob\" class=\"tw-src-ltr\">\n<div class=\"oSioSc\">\n<div id=\"tw-target\">\n<div id=\"kAz1tf\" class=\"g9WsWb\">\n<div id=\"tw-target-text-container\" class=\"tw-ta-container hide-focus-ring tw-nfl\" tabindex=\"0\">\n<p id=\"tw-target-text\" class=\"tw-data-text tw-text-large tw-ta\" dir=\"ltr\" data-placeholder=\"Traducci&oacute;n\"><span lang=\"es\">En las personas con diabetes Tipo 1, el sistema inmunol&oacute;gico del cuerpo confunde las c&eacute;lulas beta productoras de insulina como objetos extra&ntilde;os y las ataca. Con el tiempo, las personas con diabetes Tipo 1 no tienen ninguna de estas c&eacute;lulas beta y, por lo tanto, no pueden producir su propia insulina.<\/span><\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"g knavi obcontainer mod\" data-md=\"77\" data-hveid=\"CAoQAA\" data-ved=\"2ahUKEwj-3uaR1rboAhVPCKwKHYrYBM8QkCkwAHoECAoQAA\">\n<div id=\"tw-main\" data-hveid=\"CAoQAQ\">\n<div id=\"tw-container\" class=\"vk_c\" data-cp=\"1\" data-nnttsvi=\"1\" data-sm=\"1\" data-sugg-time=\"500\" data-sugg-url=\"https:\/\/clients1.google.com\/complete\/search\" data-uilc=\"es-419\">\n<div>\n<div class=\"jhH5U\">\n<div id=\"tw-ob\" class=\"tw-src-ltr\">\n<div class=\"oSioSc\">\n<div id=\"tw-target\">\n<div id=\"kAz1tf\" class=\"g9WsWb\">\n<div id=\"tw-target-text-container\" class=\"tw-ta-container hide-focus-ring tw-nfl\" tabindex=\"0\">\n<p id=\"tw-target-text\" class=\"tw-data-text tw-text-large tw-ta\" dir=\"ltr\" data-placeholder=\"Traducci&oacute;n\"><span lang=\"es\">Pero, &iquest;qu&eacute; pasar&iacute;a si pudi&eacute;ramos prevenir o evitar esta respuesta autoinmune que ataca a las c&eacute;lulas beta? Este es el foco de la investigaci&oacute;n de inmunoterapia para curar la diabetes Tipo 1. La investigaci&oacute;n actual est&aacute; buscando<\/span><\/p>\n<ul>\n<li class=\"tw-data-text tw-text-large tw-ta\" dir=\"ltr\" data-placeholder=\"Traducci&oacute;n\"><span lang=\"es\">c&oacute;mo evitar que el sistema inmunol&oacute;gico ataque las c&eacute;lulas de los islotes en primer lugar <\/span><\/li>\n<li class=\"tw-data-text tw-text-large tw-ta\" dir=\"ltr\" data-placeholder=\"Traducci&oacute;n\"><span lang=\"es\">formas de ralentizar o detener la respuesta autoinmune una vez que ha comenzado en pacientes recientemente diagnosticados que a&uacute;n se encuentran en la fase de luna de miel <\/span><\/li>\n<li class=\"tw-data-text tw-text-large tw-ta\" dir=\"ltr\" data-placeholder=\"Traducci&oacute;n\"><span lang=\"es\">c&oacute;mo evitar que el sistema inmunol&oacute;gico ataque las c&eacute;lulas beta implantadas junto con la terapia con c&eacute;lulas beta <\/span><\/li>\n<\/ul>\n<p><span lang=\"es\">En &uacute;ltima instancia, una cura biol&oacute;gica para la diabetes Tipo 1 probablemente incluir&aacute; una combinaci&oacute;n de terapia con c&eacute;lulas beta e inmunoterapia, tanto para restablecer el funcionamiento de las c&eacute;lulas beta como para protegerlas de la respuesta autoinmune.<\/span><\/p>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Este Recurso en&nbsp;Investigaci&oacute;n sobre Diabetes Tipo 1&nbsp;fue creado en colaboraci&oacute;n con JDRF como parte de la Alianza&nbsp;JDRF &ndash; Beyond Type 1&nbsp; &nbsp; En las personas con diabetes Tipo 1, el sistema inmunol&oacute;gico del cuerpo confunde las c&eacute;lulas beta productoras de insulina como objetos extra&ntilde;os y las ataca. Con el tiempo, las personas con diabetes Tipo [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":34262,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"page_templates\/content.php","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-34261","page","type-page","status-publish","has-post-thumbnail","hentry","diabetes-types-tipo-1","tags-cureresearch-es"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Inmunoterapias | Beyond Type 1<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/beyondtype1.org\/es\/inmunoterapias\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Inmunoterapias | Beyond Type 1\" \/>\n<meta property=\"og:description\" content=\"Este Recurso en&nbsp;Investigaci&oacute;n sobre Diabetes Tipo 1&nbsp;fue creado en colaboraci&oacute;n con JDRF como parte de la Alianza&nbsp;JDRF &ndash; Beyond Type 1&nbsp; &nbsp; En las personas con diabetes Tipo 1, el sistema inmunol&oacute;gico del cuerpo confunde las c&eacute;lulas beta productoras de insulina como objetos extra&ntilde;os y las ataca. Con el tiempo, las personas con diabetes Tipo [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/beyondtype1.org\/es\/inmunoterapias\/\" \/>\n<meta property=\"og:site_name\" content=\"Beyond Type 1\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/beyondtype1\" \/>\n<meta property=\"article:modified_time\" content=\"2024-12-09T19:08:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/beyondtype1.org\/wp-content\/uploads\/2024\/12\/BT1-IMMUNOTHERAPIES-HEADER-1200x429-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"429\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@BeyondType1\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/beyondtype1.org\/es\/inmunoterapias\/\",\"url\":\"https:\/\/beyondtype1.org\/es\/inmunoterapias\/\",\"name\":\"Inmunoterapias | Beyond Type 1\",\"isPartOf\":{\"@id\":\"https:\/\/beyondtype1.org\/es\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/beyondtype1.org\/es\/inmunoterapias\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/beyondtype1.org\/es\/inmunoterapias\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/beyondtype1.org\/wp-content\/uploads\/2024\/12\/BT1-IMMUNOTHERAPIES-HEADER-1200x429-1.png\",\"datePublished\":\"2020-03-25T19:07:16+00:00\",\"dateModified\":\"2024-12-09T19:08:25+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/beyondtype1.org\/es\/inmunoterapias\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/beyondtype1.org\/es\/inmunoterapias\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/beyondtype1.org\/es\/inmunoterapias\/#primaryimage\",\"url\":\"https:\/\/beyondtype1.org\/wp-content\/uploads\/2024\/12\/BT1-IMMUNOTHERAPIES-HEADER-1200x429-1.png\",\"contentUrl\":\"https:\/\/beyondtype1.org\/wp-content\/uploads\/2024\/12\/BT1-IMMUNOTHERAPIES-HEADER-1200x429-1.png\",\"width\":1200,\"height\":429},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/beyondtype1.org\/es\/inmunoterapias\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/beyondtype1.org\/es\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Inmunoterapias\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/beyondtype1.org\/es\/#website\",\"url\":\"https:\/\/beyondtype1.org\/es\/\",\"name\":\"Beyond Type 1\",\"description\":\"Beyond Type 1 is the largest diabetes org online, funding advocacy, education and cure research.\",\"publisher\":{\"@id\":\"https:\/\/beyondtype1.org\/es\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/beyondtype1.org\/es\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/beyondtype1.org\/es\/#organization\",\"name\":\"Beyond Type 1\",\"url\":\"https:\/\/beyondtype1.org\/es\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/beyondtype1.org\/es\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/beyondtype1.org\/wp-content\/uploads\/2025\/08\/header-logo.svg\",\"contentUrl\":\"https:\/\/beyondtype1.org\/wp-content\/uploads\/2025\/08\/header-logo.svg\",\"width\":56,\"height\":56,\"caption\":\"Beyond Type 1\"},\"image\":{\"@id\":\"https:\/\/beyondtype1.org\/es\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/beyondtype1\",\"https:\/\/x.com\/BeyondType1\",\"http:\/\/instagram.com\/BeyondType1\/\",\"https:\/\/www.youtube.com\/c\/BeyondType1\",\"https:\/\/www.tiktok.com\/@beyondtype1\",\"https:\/\/www.linkedin.com\/company\/beyond-type1\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Inmunoterapias | Beyond Type 1","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/beyondtype1.org\/es\/inmunoterapias\/","og_locale":"es_ES","og_type":"article","og_title":"Inmunoterapias | Beyond Type 1","og_description":"Este Recurso en&nbsp;Investigaci&oacute;n sobre Diabetes Tipo 1&nbsp;fue creado en colaboraci&oacute;n con JDRF como parte de la Alianza&nbsp;JDRF &ndash; Beyond Type 1&nbsp; &nbsp; En las personas con diabetes Tipo 1, el sistema inmunol&oacute;gico del cuerpo confunde las c&eacute;lulas beta productoras de insulina como objetos extra&ntilde;os y las ataca. Con el tiempo, las personas con diabetes Tipo [&hellip;]","og_url":"https:\/\/beyondtype1.org\/es\/inmunoterapias\/","og_site_name":"Beyond Type 1","article_publisher":"https:\/\/www.facebook.com\/beyondtype1","article_modified_time":"2024-12-09T19:08:25+00:00","og_image":[{"width":1200,"height":429,"url":"https:\/\/beyondtype1.org\/wp-content\/uploads\/2024\/12\/BT1-IMMUNOTHERAPIES-HEADER-1200x429-1.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_site":"@BeyondType1","twitter_misc":{"Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/beyondtype1.org\/es\/inmunoterapias\/","url":"https:\/\/beyondtype1.org\/es\/inmunoterapias\/","name":"Inmunoterapias | Beyond Type 1","isPartOf":{"@id":"https:\/\/beyondtype1.org\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/beyondtype1.org\/es\/inmunoterapias\/#primaryimage"},"image":{"@id":"https:\/\/beyondtype1.org\/es\/inmunoterapias\/#primaryimage"},"thumbnailUrl":"https:\/\/beyondtype1.org\/wp-content\/uploads\/2024\/12\/BT1-IMMUNOTHERAPIES-HEADER-1200x429-1.png","datePublished":"2020-03-25T19:07:16+00:00","dateModified":"2024-12-09T19:08:25+00:00","breadcrumb":{"@id":"https:\/\/beyondtype1.org\/es\/inmunoterapias\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/beyondtype1.org\/es\/inmunoterapias\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/beyondtype1.org\/es\/inmunoterapias\/#primaryimage","url":"https:\/\/beyondtype1.org\/wp-content\/uploads\/2024\/12\/BT1-IMMUNOTHERAPIES-HEADER-1200x429-1.png","contentUrl":"https:\/\/beyondtype1.org\/wp-content\/uploads\/2024\/12\/BT1-IMMUNOTHERAPIES-HEADER-1200x429-1.png","width":1200,"height":429},{"@type":"BreadcrumbList","@id":"https:\/\/beyondtype1.org\/es\/inmunoterapias\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/beyondtype1.org\/es\/"},{"@type":"ListItem","position":2,"name":"Inmunoterapias"}]},{"@type":"WebSite","@id":"https:\/\/beyondtype1.org\/es\/#website","url":"https:\/\/beyondtype1.org\/es\/","name":"Beyond Type 1","description":"Beyond Type 1 is the largest diabetes org online, funding advocacy, education and cure research.","publisher":{"@id":"https:\/\/beyondtype1.org\/es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/beyondtype1.org\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/beyondtype1.org\/es\/#organization","name":"Beyond Type 1","url":"https:\/\/beyondtype1.org\/es\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/beyondtype1.org\/es\/#\/schema\/logo\/image\/","url":"https:\/\/beyondtype1.org\/wp-content\/uploads\/2025\/08\/header-logo.svg","contentUrl":"https:\/\/beyondtype1.org\/wp-content\/uploads\/2025\/08\/header-logo.svg","width":56,"height":56,"caption":"Beyond Type 1"},"image":{"@id":"https:\/\/beyondtype1.org\/es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/beyondtype1","https:\/\/x.com\/BeyondType1","http:\/\/instagram.com\/BeyondType1\/","https:\/\/www.youtube.com\/c\/BeyondType1","https:\/\/www.tiktok.com\/@beyondtype1","https:\/\/www.linkedin.com\/company\/beyond-type1\/"]}]}},"_links":{"self":[{"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/pages\/34261","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/comments?post=34261"}],"version-history":[{"count":0,"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/pages\/34261\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/media\/34262"}],"wp:attachment":[{"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/media?parent=34261"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}